Skip to main content

Advertisement

Log in

Conditional survival after surgery for metastatic tumors of the spine: does prognosis change over time?

  • Original Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

Purpose

Conditional survival (CS) provides a dynamic prediction of patient survival by incorporating the time an individual has already survived given their disease specific characteristics. The objective of the current study was to estimate CS among patients after surgery for spinal cord compression or spinal instability, as well as stratify CS according to relevant patient- and disease-related characteristics.

Methods

The clinical outcomes of 361 patients undergoing surgical management of metastatic spinal tumors were retrospectively analyzed. Stratification of this cohort according to disease and surgery-specific characteristics allowed for univariate and multivariate statistical analyses of our study population. Observed overall and conditional survival estimates were calculated by the Kaplan–Meier method.

Results

12-month conditional survival in patients undergoing surgical management of metastatic spine tumors increased from 57% at baseline to 70% at 24 months following spine surgery. Overall survival (OS) was influenced by CCI grade, Katagiri tumor type, presence of lung metastasis, type of spine surgery, presence of postoperative systemic therapy and ambulatory status at follow-up. Analyses of OS and CS by prognostic strata were similar with exception of stratification by surgery type. Differences in survival between strata tend to converge over time. Unfavorable factors for OS appear to be less relevant after a period of 24 months following spine surgery.

Conclusion

Patients after surgery for metastatic tumors of the spine can expect a positive trend in conditional survival as survivorship increases. Even patients with a more severe disease can be encouraged with gains in conditional survival over time.

Level of evidence

Level IV (retrospective cohort study).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Availability of data and material

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Code availability

The R code generated during the current study are available from the corresponding author on reasonable request.

References

  1. Ederer F, Axtell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101–121

    CAS  PubMed  Google Scholar 

  2. Henson DE, Ries LAG (1994) On the estimation of survival. Semin Surg Oncol 10:2–6. https://doi.org/10.1002/ssu.2980100103

    Article  CAS  PubMed  Google Scholar 

  3. Henson DE, Ries LA, Carriaga MT (1995) Conditional survival of 56,268 patients with breast cancer. Cancer 76:237–242. https://doi.org/10.1002/1097-0142(19950715)76:2%3c237::aid-cncr2820760213%3e3.0.co;2-j

    Article  CAS  PubMed  Google Scholar 

  4. Hieke S, Kleber M, König C et al (2015) Conditional survival: a useful concept to provide information on how prognosis evolves over time. Clin Cancer Res Off J Am Assoc Cancer Res 21:1530–1536. https://doi.org/10.1158/1078-0432.CCR-14-2154

    Article  Google Scholar 

  5. Zabor EC, Gonen M, Chapman PB, Panageas KS (2013) Dynamic prognostication using conditional survival estimates. Cancer 119:3589–3592. https://doi.org/10.1002/cncr.28273

    Article  PubMed  Google Scholar 

  6. Wancata LM, Banerjee M, Muenz DG et al (2016) Conditional survival in advanced colorectal cancer and surgery. J Surg Res 201:196–201. https://doi.org/10.1016/j.jss.2015.10.021

    Article  PubMed  Google Scholar 

  7. Brouwer NPM, Bos ACRK, Lemmens VEPP et al (2018) An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients. Int J Cancer 143:2758–2766. https://doi.org/10.1002/ijc.31785

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Shigeta K, Kikuchi E, Hagiwara M et al (2017) The conditional survival with time of intravesical recurrence of upper tract urothelial carcinoma. J Urol 198:1278–1285. https://doi.org/10.1016/j.juro.2017.06.073

    Article  PubMed  Google Scholar 

  9. Kim Y, Ejaz A, Spolverato G et al (2015) Conditional survival after surgical resection of gastric cancer: a multi-institutional analysis of the us gastric cancer collaborative. Ann Surg Oncol 22:557–564. https://doi.org/10.1245/s10434-014-4116-5

    Article  PubMed  Google Scholar 

  10. Farah P, Blanda R, Kromer C et al (2016) Conditional survival after diagnosis with malignant brain and central nervous system tumor in the United States, 1995–2012. J Neurooncol 128:419–429. https://doi.org/10.1007/s11060-016-2127-8

    Article  PubMed  Google Scholar 

  11. Macedo F, Ladeira K, Pinho F et al (2017) Bone metastases: an overview. Oncol Rev 11:321. https://doi.org/10.4081/oncol.2017.321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Rose PS, Buchowski JM (2011) Metastatic disease in the thoracic and lumbar spine: evaluation and management. JAAOS–J Am Acad Orthop Surg 19:37–48

    Article  Google Scholar 

  13. Gasbarrini A, Cappuccio M, Mirabile L et al (2004) Spinal metastases: treatment evaluation algorithm. Eur Rev Med Pharmacol Sci 8:265–274

    CAS  PubMed  Google Scholar 

  14. Kato S, Demura S, Shinmura K et al (2021) Surgical metastasectomy in the spine: a review article. Oncologist 26:e1833–e1843. https://doi.org/10.1002/onco.13840

    Article  PubMed  PubMed Central  Google Scholar 

  15. Katagiri H, Okada R, Takagi T et al (2014) New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med 3:1359–1367. https://doi.org/10.1002/cam4.292

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kumar N, Ramos MRD, Patel R et al (2021) The “spinal metastasis invasiveness index”: a novel scoring system to assess surgical invasiveness. Spine 46:478–485. https://doi.org/10.1097/BRS.0000000000003823

    Article  PubMed  Google Scholar 

  17. Chicco D, Tötsch N, Jurman G (2021) The Matthews correlation coefficient (MCC) is more reliable than balanced accuracy, bookmaker informedness, and markedness in two-class confusion matrix evaluation. BioData Min 14:13. https://doi.org/10.1186/s13040-021-00244-z

    Article  PubMed  PubMed Central  Google Scholar 

  18. Volinsky CT, Raftery AE (2000) Bayesian information criterion for censored survival models. Biometrics 56:256–262. https://doi.org/10.1111/j.0006-341X.2000.00256.x

    Article  CAS  PubMed  Google Scholar 

  19. Zabor EC, Gonen M (2018) condsurv: conditional survival estimates and plots. R package version 1.0.0.

  20. Rothrock RJ, Barzilai O, Reiner AS et al (2020) Survival trends after surgery for spinal metastatic tumors: 20-year cancer center experience. Neurosurgery 88:402–412. https://doi.org/10.1093/neuros/nyaa380

    Article  PubMed Central  Google Scholar 

  21. Wright E, Ricciardi F, Arts M et al (2018) Metastatic spine tumor epidemiology: comparison of trends in surgery across two decades and three continents. World Neurosurg 114:e809–e817. https://doi.org/10.1016/j.wneu.2018.03.091

    Article  PubMed  Google Scholar 

  22. Tobin NP, Foukakis T, De Petris L, Bergh J (2015) The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer. J Intern Med 278:545–570. https://doi.org/10.1111/joim.12429

    Article  CAS  PubMed  Google Scholar 

  23. Bilsky MH, Laufer I, Burch S (2009) Shifting paradigms in the treatment of metastatic spine disease. Spine 34:S101–S107. https://doi.org/10.1097/BRS.0b013e3181bac4b2

    Article  PubMed  Google Scholar 

  24. Kim CH, Chung CK, Jahng T-A, Kim HJ (2011) Resumption of ambulatory status after surgery for nonambulatory patients with epidural spinal metastasis. Spine J 11:1015–1023. https://doi.org/10.1016/j.spinee.2011.09.007

    Article  PubMed  Google Scholar 

  25. Yang SB, Cho W, Chang U-K (2012) Analysis of prognostic factors relating to postoperative survival in spinal metastases. J Korean Neurosurg Soc 51:127–134. https://doi.org/10.3340/jkns.2012.51.3.127

    Article  PubMed  PubMed Central  Google Scholar 

  26. Heiden JJ, Goodin SR, Mormino MA et al (2021) Early ambulation after hip fracture surgery is associated with decreased 30-day mortality. J Am Acad Orthop Surg 29:e238–e242. https://doi.org/10.5435/JAAOS-D-20-00554

    Article  PubMed  Google Scholar 

  27. Mechas CA, Isla AE, Abbenhaus EJ et al (2022) Clinical outcomes following distal femur replacement for periprosthetic distal femur fractures: a systematic review and meta-analysis. J Arthroplasty 37:1002–1008. https://doi.org/10.1016/j.arth.2022.01.054

    Article  PubMed  Google Scholar 

  28. Myeroff CM, Anderson JP, Sveom DS, Switzer JA (2018) Predictors of mortality in elder patients with proximal humeral fracture. Geriatr Orthop Surg Rehabil 9:2151458517728155. https://doi.org/10.1177/2151458517728155

    Article  PubMed  Google Scholar 

  29. Muraki S, Yamamoto S, Ishibashi H, Nakamura K (2006) Factors associated with mortality following hip fracture in Japan. J Bone Miner Metab 24:100–104. https://doi.org/10.1007/s00774-005-0654-z

    Article  PubMed  Google Scholar 

  30. Ahmed AK, Goodwin CR, Heravi A et al (2018) Predicting survival for metastatic spine disease: a comparison of nine scoring systems. Spine J 18:1804–1814. https://doi.org/10.1016/j.spinee.2018.03.011

    Article  PubMed  Google Scholar 

  31. Ruatta F, Derosa L, Escudier B et al (2019) Prognosis of renal cell carcinoma with bone metastases: experience from a large cancer centre. Eur J Cancer 107:79–85. https://doi.org/10.1016/j.ejca.2018.10.023

    Article  CAS  PubMed  Google Scholar 

  32. Tokuhashi Y, Matsuzaki H, Oda H et al (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 30:2186–2191. https://doi.org/10.1097/01.brs.0000180401.06919.a5

    Article  PubMed  Google Scholar 

  33. Amelot A, Moles A, Cristini J et al (2016) Predictors of survival in patients with surgical spine multiple myeloma metastases. Surg Oncol 25:178–183. https://doi.org/10.1016/j.suronc.2016.05.012

    Article  PubMed  Google Scholar 

  34. Greipp PR, Miguel JS, Durie BGM et al (2005) International staging system for multiple myeloma. J Clin Oncol 23:3412–3420. https://doi.org/10.1200/JCO.2005.04.242

    Article  PubMed  Google Scholar 

  35. Santini D, Tampellini M, Vincenzi B et al (2012) Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol 23:2072–2077. https://doi.org/10.1093/annonc/mdr572

    Article  CAS  PubMed  Google Scholar 

  36. Takagi T, Katagiri H, Kim Y et al (2015) Skeletal metastasis of unknown primary origin at the initial visit: a retrospective analysis of 286 cases. PLoS ONE 10:e0129428. https://doi.org/10.1371/journal.pone.0129428

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Kawamura H, Yamaguchi T, Yano Y et al (2018) Characteristics and prognostic factors of bone metastasis in patients with colorectal cancer. Dis Colon Rectum 61:673–678. https://doi.org/10.1097/DCR.0000000000001071

    Article  PubMed  Google Scholar 

  38. Tomita K, Kawahara N, Kobayashi T et al (2001) Surgical strategy for spinal metastases. Spine 26:298–306. https://doi.org/10.1097/00007632-200102010-00016

    Article  CAS  PubMed  Google Scholar 

  39. Du Z, Guo W, Yang R et al (2016) What is the value of surgical intervention for sacral metastases? PLoS ONE 11:e0168313. https://doi.org/10.1371/journal.pone.0168313

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Sioutos PJ, Arbit E, Meshulam CF, Galicich JH (1995) Spinal metastases from solid tumors. Anal Factors Affect Surv Cancer 76:1453–1459. https://doi.org/10.1002/1097-0142(19951015)76:8%3c1453::AID-CNCR2820760824%3e3.0.CO;2-T

    Article  CAS  Google Scholar 

  41. Song K, Lin K, Guan H, Li F (2020) Conditional survival analysis for spinal chondrosarcoma patients after surgical resection. Spine 45:1110–1117. https://doi.org/10.1097/BRS.0000000000003494

    Article  PubMed  Google Scholar 

  42. Huang J-F, Chen D, Zheng X-Q et al (2019) Conditional survival and changing risk profile in patients with chordoma: a population-based longitudinal cohort study. J Orthop Surg 14:181. https://doi.org/10.1186/s13018-019-1225-7

    Article  Google Scholar 

  43. Schirren J, Schirren M, Lampl L, Sponholz S (2017) Surgery for pulmonary metastases: quo vadis? Eur J Cardiothorac Surg 51:408–410. https://doi.org/10.1093/ejcts/ezw441

    Article  PubMed  Google Scholar 

  44. Orlandi A, Pontolillo L, Mele C et al (2021) Liver metastasectomy for metastatic breast cancer patients: a single institution retrospective analysis. J Pers Med 11:187. https://doi.org/10.3390/jpm11030187

    Article  PubMed  PubMed Central  Google Scholar 

  45. Wibmer C, Leithner A, Hofmann G et al (2011) Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems. Spine 36:1977–1986. https://doi.org/10.1097/BRS.0b013e3182011f84

    Article  PubMed  Google Scholar 

  46. Chang SY, Chang B-S, Lee C-K, Kim H (2019) Remaining systemic treatment options: a valuable predictor of survival and functional outcomes after surgical treatment for spinal metastasis. Orthop Surg 11:552–559. https://doi.org/10.1111/os.12501

    Article  PubMed  PubMed Central  Google Scholar 

  47. Mesfin A, Buchowski JM, Gokaslan ZL, Bird JE (2015) Management of metastatic cervical spine tumors. JAAOS–J Am Acad Orthop Surg 23:38–46. https://doi.org/10.5435/JAAOS-23-01-38

    Article  Google Scholar 

  48. Boriani S, Weinstein JN, Biagini R (1997) Primary bone tumors of the spine. Terminol Surg Stag Spine 22:1036–1044. https://doi.org/10.1097/00007632-199705010-00020

    Article  CAS  Google Scholar 

Download references

Funding

There is no funding source.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dimitriy Kondrashov.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethics approval

The study was approved by the Hospital Institutional Review Board and complied with International Ethical Guidelines for Biomedical Research, Declaration of Helsinki, and local laws.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Consent for publication

Patients signed informed consent regarding publishing their data and photographs.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zaborovskii, N., Schlauch, A., Shapton, J. et al. Conditional survival after surgery for metastatic tumors of the spine: does prognosis change over time?. Eur Spine J 32, 1010–1020 (2023). https://doi.org/10.1007/s00586-023-07548-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-023-07548-0

Keywords

Navigation